Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TITANIUM1: Tinostamustine Conditioning for ASCT in MM
NCT03687125Phase 2Terminated
- Sponsor
- Mundipharma
- Start
- Oct 2018
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of tinostamustine in multiple myeloma (MM), sponsored by Mundipharma. Started Oct 2018; status: terminated.
02
Drugs
tinostamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT03687125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03687125.